Navigation Links
DuPont Pioneer Launches Open Innovation Website
Date:7/17/2017

DuPont Pioneer today announced the launch of a new component of its long-standing innovation strategy. A website (openinnovation.pioneer.com) dedicated to connecting third-party innovators with DuPont Pioneer scientists is now available and focused on five strategic areas – trait discovery, plant breeding, enabling technologies, biologicals and digital solutions.

“DuPont Pioneer is building on its long history of collaboration to advance science-based customer solutions by enhancing its open innovation strategy,” said Neal Gutterson, vice president, Research and Development for DuPont Pioneer. “Through this broad-based approach, we make available our resources to collaborators and develop the most innovative technologies in agriculture, then apply our production scale and route to market to rapidly deploy novel solutions to farmers around the world.”

Currently there are three active grant opportunities posted on the open innovation web portal targeted to disease resistance; advancements in template-based CRISPR-Cas genome editing; and, big data cluster analysis.

Potential collaborators also are encouraged to submit ideas for consideration beyond the currently available grants. Terms for selected open innovation projects are tailored on a case-by-case basis in a discussion with DuPont Pioneer’s open innovation team.

DuPont Pioneer is the world's leading developer and supplier of advanced plant genetics, providing high-quality seeds to farmers in more than 90 countries. Pioneer provides agronomic support and services to help increase farmer productivity and profitability and strives to develop sustainable agricultural systems for people everywhere. Science with Service Delivering Success®.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials and services since 1802. The company believes that by collaborating with customers, governments, NGOs and thought leaders, we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements: This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology and, in general, for products for the agriculture industry; outcome of significant litigation and environmental matters, including realization of associated indemnification assets, if any; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could affect demand as well as availability of products for the agriculture industry; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses; and risks related to the agreement entered on December 11, 2015, with The Dow Chemical Company pursuant to which the companies have agreed to effect an all-stock merger of equals, including the completion of the proposed transaction on anticipated terms and timing, the ability to fully and timely realize the expected benefits of the proposed transaction and risks related to the intended business separations contemplated to occur after the completion of the proposed transaction. The company undertakes no duty to publicly revise or update any forward-looking statements as a result of future developments, or new information or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

®, ™, SM Trademarks and service marks of DuPont, Pioneer or their respective owners.

Read the full story at http://www.prweb.com/releases/dupont-pioneer-seed/open-innovation-website/prweb14514247.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. DuPont and Bock Announce Strategic Partnership, Expanding Biogas Enzymes Distribution Footprint
2. DuPont Pioneer Secures Exclusive Rights to ERS Genomics’ CRISPR-Cas Patent Portfolio for Agriculture
3. DuPont Biofuels Leader Jan Koninckx Speaks at 2017 Sustainable Business Summit
4. DuPont’s William Feehery to Keynote ACS Conference on Green Chemistry & Engineering
5. DuPont Pioneer and Vilnius University Announce CRISPR-Cas Patent Grant
6. DuPont Pioneer Provides Access to Proprietary Phenotyping Technology; Sponsors Purdue Endowed Chair in Plant Sciences
7. DuPont Announces New, Complete Solutions to Maximize Soybean Yields
8. DuPont Industrial Biosciences Leader Presents Major Advances in Biomaterials at 2017 Advanced Bioeconomy Leadership Conference
9. Student-Run DuPont Plant Sciences Symposium Series Kicks Off at University of Missouri
10. DuPont Industrial Biosciences to Begin New Research Aimed to Enable Global Access for Protein Medications
11. Industry Leaders DuPont & Archer Daniels Midland Win Platts Global Energy Breakthrough Solution of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... , ... June 26, 2020 , ... ... representing security solutions providers, today announced its strong opposition to the recently introduced ... would impose a blanket ban on most federal use of nearly all biometric ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... complex indoor environments, announced today that Derek Fournier has been appointed CEO and ... of the Board, effective immediately. , “DeCurtis Corporation has been on an ...
(Date:6/23/2020)... , ... June 22, 2020 , ... ... glutamine antagonist, DRP-104, will be presented June 22-24 during the American Association for ... DRP-104; and, the other profiles the potent, consistent single agent activity in KEAP1 ...
(Date:6/19/2020)... (PRWEB) , ... June 18, 2020 , ... The ... Its goal is to join forces to radically prolong life and find a way ... the aging period. This project was supported by various scientists from all over the ...
Breaking Biology Technology:
(Date:5/28/2020)... ... May 28, 2020 , ... ... enzyme solution for adjunct liquefaction: AMYLEX® 6T. The innovative enzyme enables numerous ... into new segments with locally-sourced raw materials, improve productivity, maximize yield, ensure ...
(Date:5/26/2020)... FRANCISCO (PRWEB) , ... May ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that Gritstone ... of T-cell receptor (TCR)-mimetic bispecific T cell engagers and TCR-based therapeutics, has ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... technology-based services specializing in background and medical screening, announces the launch of ... and keeping their workforce safe. The new service is provided by ClearStar’s ...
Breaking Biology News(10 mins):